These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 20128781

  • 21. Radical prostatectomy as initial monotherapy for patients with pathologically confirmed high-grade prostate cancer.
    Bahler CD, Foster RS, Bihrle R, Beck SD, Gardner TA, Sundaram CP, Masterson TA, Cheng L, Koch MO.
    BJU Int; 2010 May; 105(10):1372-6. PubMed ID: 19863521
    [Abstract] [Full Text] [Related]

  • 22. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
    Boorjian SA, Bianco FJ, Scardino PT, Eastham JA.
    BJU Int; 2005 Oct; 96(6):773-6. PubMed ID: 16153197
    [Abstract] [Full Text] [Related]

  • 23. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
    Moussa AS, Li J, Soriano M, Klein EA, Dong F, Jones JS.
    BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303
    [Abstract] [Full Text] [Related]

  • 24. Maximum tumor diameter: a simple independent predictor for biochemical recurrence after radical prostatectomy.
    Fukuhara H, Kume H, Suzuki M, Fujimura T, Enomoto Y, Nishimatsu H, Ishikawa A, Homma Y.
    Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):244-7. PubMed ID: 20567255
    [Abstract] [Full Text] [Related]

  • 25. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
    Kupelian P, Katcher J, Levin H, Zippe C, Klein E.
    Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
    [Abstract] [Full Text] [Related]

  • 26. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249
    [Abstract] [Full Text] [Related]

  • 27. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence.
    O'Neil LM, Walsh S, Cohen RJ, Lee S.
    BJU Int; 2015 Oct 01; 116 Suppl 3():42-8. PubMed ID: 26218868
    [Abstract] [Full Text] [Related]

  • 28. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.
    Yokomizo A, Murai M, Baba S, Ogawa O, Tsukamoto T, Niwakawa M, Tobisu K, Kinukawa N, Naito S.
    BJU Int; 2006 Sep 01; 98(3):549-53. PubMed ID: 16925752
    [Abstract] [Full Text] [Related]

  • 29. Is prostate-specific antigen (PSA) density better than the preoperative PSA level in predicting early biochemical recurrence of prostate cancer after radical prostatectomy?
    Jones TD, Koch MO, Bunde PJ, Cheng L.
    BJU Int; 2006 Mar 01; 97(3):480-4. PubMed ID: 16469012
    [Abstract] [Full Text] [Related]

  • 30. Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients.
    Chun FK, Briganti A, Antebi E, Graefen M, Currlin E, Steuber T, Schlomm T, Walz J, Haese A, Friedrich MG, Ahyai SA, Eichelberg C, Salomon G, Gallina A, Erbersdobler A, Perrotte P, Heinzer H, Huland H, Karakiewicz PI.
    BJU Int; 2006 Dec 01; 98(6):1204-9. PubMed ID: 17034506
    [Abstract] [Full Text] [Related]

  • 31. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
    Walz J, Chun FK, Klein EA, Reuther A, Graefen M, Huland H, Karakiewicz PI.
    Eur Urol; 2009 Feb 01; 55(2):412-19. PubMed ID: 19027223
    [Abstract] [Full Text] [Related]

  • 32. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer.
    Vis AN, Schröder FH, van der Kwast TH.
    Eur Urol; 2006 Aug 01; 50(2):258-65. PubMed ID: 16413660
    [Abstract] [Full Text] [Related]

  • 33. Tumour length of the largest focus predicts prostate-specific antigen-based recurrence after radical prostatectomy in clinically localized prostate cancer.
    Mizuno R, Nakashima J, Mukai M, Okita H, Kosugi M, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Oya M.
    BJU Int; 2009 Nov 01; 104(9):1215-8. PubMed ID: 19389009
    [Abstract] [Full Text] [Related]

  • 34. Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate-specific antigen level: is there a difference?
    Pelzer AE, Colleselli D, Bektic J, Steiner E, Ramoner R, Mitterberger M, Schwentner C, Schaefer G, Ongarello S, Bartsch G, Horninger W.
    BJU Int; 2008 Apr 01; 101(7):822-5. PubMed ID: 18261154
    [Abstract] [Full Text] [Related]

  • 35. Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy.
    Ha YS, Kang DI, Kim JH, Joung JY, Yu J, Parihar JS, Salmasi AH, Horie S, Kim WJ, Yi Kim I.
    Can J Urol; 2014 Jun 01; 21(3):7290-7. PubMed ID: 24978359
    [Abstract] [Full Text] [Related]

  • 36. Risk stratification after radical prostatectomy in men with pathologically organ-confined prostate cancer using volume-weighted mean nuclear volume.
    Matsui Y, Utsunomiya N, Ichioka K, Ueda N, Yoshimura K, Terai A, Arai Y.
    Prostate; 2005 Aug 01; 64(3):217-23. PubMed ID: 15712275
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of modern pathological criteria for positive margins in radical prostatectomy specimens and their use for predicting biochemical recurrence.
    Bong GW, Ritenour CW, Osunkoya AO, Smith MT, Keane TE.
    BJU Int; 2009 Feb 01; 103(3):327-31. PubMed ID: 19007381
    [Abstract] [Full Text] [Related]

  • 38. The relationship between age at time of surgery and risk of biochemical failure after radical prostatectomy.
    Barlow LJ, Badalato GM, Bashir T, Benson MC, McKiernan JM.
    BJU Int; 2010 Jun 01; 105(12):1646-9. PubMed ID: 19863523
    [Abstract] [Full Text] [Related]

  • 39. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
    Kawamorita N, Saito S, Ishidoya S, Ito A, Saito H, Kato M, Arai Y.
    Int J Urol; 2009 Sep 01; 16(9):733-8. PubMed ID: 19674167
    [Abstract] [Full Text] [Related]

  • 40. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA.
    BJU Int; 2006 Jan 01; 97(1):51-5. PubMed ID: 16336328
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.